Results of a phase I/II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin VPM1002BC in patients with non-muscle invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy – SAKK 06/14

2020 ◽  
Vol 38 (12) ◽  
pp. 898
Author(s):  
Cyrill A Rentsch ◽  
George N Thalmann ◽  
Ilaria Lucca ◽  
Maciej Kwiatkowski ◽  
Grégory J Wirth ◽  
...  
2020 ◽  
Vol 6 (1) ◽  
pp. 9-23
Author(s):  
Kyle B. Zuniga ◽  
Rebecca E. Graff ◽  
David B. Feiger ◽  
Maxwell V. Meng ◽  
Sima P. Porten ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document